FDA Inspection 767479 — Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc.

Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. — FEI 1971534

The FDA completed an inspection of Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. on January 30, 2012 in Topeka, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 30, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Topeka, KS (United States)

Citations

IDCFRDescription
3121 CFR 606.20(b)Qualifications of responsible personnel